Don't drink alcohol while taking Januvia! Happy New Year!

[warsurplus]

From: Drugs.com

"Avoid drinking alcohol while taking sitagliptin. Alcohol lowers blood sugar and may increase the risk of lactic acidosis while you are taking this medicine."

Some of the side effects are nausea, stomach pain, diarrhea!

"Sitagliptin is only part of a complete program of treatment that also includes diet, exercise, weight control, and possibly other medications."

http://www.drugs.com/mtm/J/Januvia.html

[Anonymous]

Don't drink alcohol, period!!!!

[Anonymous]

Don't drink alcohol, period!!!!

Says prissy McSnotty. (don't have sex either)

[Anonymous]

because ethanol is metabolized through the Kreb's cycle, it should not be consumed by diabetics.

learn the disease state and nutritional guidelines before making uninformed posts!!

[Anonymous]

Tell that to most of the diabetics in the country, I'm sure that all "your" diabetics are compliant, right?

[Anonymous]

Says prissy McSnotty. (don't have sex either)

GFUSELF! Sex's allowed.

[Anonymous]

yeah happy new year

[Anonymous]

do you think it needs to be so black and white.... don"t.... never.... ever
get real ok

[Anonymous]

Amylin Beat Up On Byetta Slowdown


With sales of its franchise diabetes drug Byetta coming up short in the the first quarter, Amylin Pharmaceuticals is hurting.

The San Diego-based biopharma company lost $68.8 million, or 51 cents a share, compared with a loss of $49.4 million, or 38 cents a share, in the corresponding quarter last year. It also reduced its revenue forecast. It now expects $900.0 million to $950.0 million in sales for the year, down from $900.0 million to $1.0 billion.

Amylin posted revenues of $197.2 million, with $158.5 million coming from sales of Byetta and $20.2 million from Symlin, both injectible diabetes treatments. Analysts polled by Thomson Financial had expected a loss of 48 cents a share on revenue of $222.8 million. Byetta is sold in partnership with Eli Lilly. The two companies are waiting for a response from the U.S. Food and Drug Administration to expand Byetta's use to be a single-therapy treatment. Eli Lilly earns 100% on the sales of Byetta outside the United States, which were $10.5 million in the first quarter. The company also earns 50% of U.S. sales.

Amylin blamed worse-than-expected sales of Byetta in part on buying patterns among its wholesalers, who it said stocked up on the drug in the fourth quarter and were working through their inventory in the first quarter.

"We know we need to improve our execution," CEO Daniel Bradbury said on a conference call with analysts.

Robert W. Baird analyst Thomas Russo said, "We are concerned about challenges to the current business and think investors will be looking for sizable improvement from the sales and marketing fixes that they put in place."

Investors were not pleased by the loss. Shares of Amylin (nasdaq: AMLN - news - people ) closed down 10.3%, or $3.23, to $28.18.

"We believe interest will pick up with script growth and as LAR filing and additional data grow nearer," said Goldman Sachs analyst Meg Malloy. "Fundamentally, Amylin is differentiated with the only diabetes agent that enables significant blood sugar control and sustained weight loss, a $3 billion to $4 billion commercial opportunity in our view."

Earlier in the month, Amlyin received good news in the form of bad news for competitiors Pfizer (nyse: PFE - news - people ) and Nektar Therapeutics (nasdaq: NKTR - news - people ), which announced that they were changing the label on their joint-venture inhaled insulin drug Exubera due to increased instances of lung cancer during clinical trials.

[Anonymous]

"We believe interest will pick up with script growth and as LAR filing and additional data grow nearer," said Goldman Sachs analyst Meg Malloy. "Fundamentally, Amylin is differentiated with the only diabetes agent that enables significant blood sugar control and sustained weight loss, a $3 billion to $4 billion commercial opportunity in our view."

....it's all good!

[Anonymous]

I was just told today that I MUST start taking this medication. I just had a couple of margaritas, tomorrow I see the dietician. My question is, how much or if any, alcohol are you allowed, please only respond if you know what you are talking about. I'd appreciate any input. I know there are those of you (like me) that don't want to hear the truth, but i'd really like to know.

[Anonymous]

Don't drink alcohol, period!!!!

Oh shit, too late. See you in hell.

[Anonymous]

I have been on Januvia 100 once a day for the past five months. Blood sugar levels are fairly well controlled. Prior to taking this medicine the levels had shot upto 350 and are now in he 120 range. I have been rgularly drinking around 200 ml of hard spirits every day without any adverse affect.

[Anonymous]

I have been on Januvia 100 once a day for the past five months. Blood sugar levels are fairly well controlled. Prior to taking this medicine the levels had shot upto 350 and are now in he 120 range. I have been rgularly drinking around 200 ml of hard spirits every day without any adverse affect.

By chance, are you a driving instructor? We know you are a moron.

[Anonymous]

I was just prescribed Januvia and have not yet picked up my prescription. I drink at least once a week if not twice a week. I am wondering if it is alright to drink on occasion or not.

[Anonymous]

If you look in the Januvia label there is nothing about avoiding alcohol.

[Anonymous]

Very smart